Improving the uptake of long acting reversible contraception: A review

Minerva Ginecologica

Volumn 65, Issue 3, 2013, Pages 241-252

  Michie, L ^a,b   Cameron, S T ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Chalmers Sexual Health Centre   (United Kingdom)

Author keywords

Contraception; Contraception, barrier; Pregnancy, unplanned

Indexed keywords

ABORTION; CONTRACEPTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PRACTITIONER; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LONG ACTING REVERSIBLE CONTRACEPTION; MEDICAL EDUCATION; PREGNANCY RATE; PREGNANCY TERMINATION; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RURAL AREA; UNPLANNED PREGNANCY; URBAN AREA;

CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FEMALE; HUMANS; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, MEDICATED; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY, UNPLANNED;

EID: 84882387038     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. nd edition. 2012. [Internet] Available at http://apps.who.int/iris/bitstream/10665/70914/1/9789241548434-eng.pdf [cited 201, Mar. 15].
2. Glasier A, Lakha F. Unintended pregnancy and use of emergency contraception among a large cohort of women attending for ante-natal care or abortion in Scotland. Lancet 2006;368:1782-7.
3. Trussell J. The cost of unintended pregnancy in the United States. Contraception 2007;75:168-70.
4. Montouchet M, Trussell J. Unintended pregnancies in England in 2010: costs to the National Health Service (NHS). Contraception 2013;87:149-53.
5. Trussell J, Henry N, Hassan F, Prezioso A, Law A, Filonenko A. Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception 2013;87:154-61.
6. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspectives on Sexual and Reproductive Health 2006;38:90-6.
7. th revised edition. New York: Ardent Media; 2008. p. 19-48.
8. Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive methods: A review of the literature. Eur J Contracept Reprod Health Care 2010;15:4-16.
9. National Institute for Health and Clinical Excellence. Long-acting Reversible Contraception. Clinical Guideline 30 2005 [Internet]. Available at http://publications.nice.org.uk/long-acting-reversible-contraception-cg30 [cited 2013, Mar. 18]
10. Grimes DA. Forgettable contraception. Contraception 2009;80:497-9.
11. Espey E, Ogbum T. Long-acting reversible contraception. Intrauterine devices and the contraceptive implant. Obstetrics and Gynecology 2011;117:705-19.
12. United Nations. Department of Economic and Social Affairs, Population Division (2011). World Contraceptive Use 2010. [Internet]. Available at http://www.un.org/esa/population/publications/wcu2010/Main.html [cited 2013, Mar. 18].
13. Lader D. Office for National Statistics. Opinions Survey Report No. 41. Contraception and Sexual Health, 2008/09 2009. [Internet]. Available at http://www.ons. gov. uk/ons/rel/lifestyles/contraception-and-sexualhealth/2008- 09/index.html [cited 2013, Mar. 18].
14. Glasier A, Scorer J, Bigrigg. Attitudes of women in Scotland to contraception: a qualitative study to explore the acceptability of long-acting methods. Journal of Family Planning and Reproductive Healthcare 2008;34:213-7.
15. Asker C, Stokes-Lampard H, Beaven J, Wilson S. What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study. J Fam Plann Reprod Health Care 2006;32:89-94.
16. Fleming KL, Sokoloff A, Raine TR. Attitudes and beliefs about the intrauterine device among teenagers and young women. Contraception 2010;82:178-82.
17. Michie L, Cameron ST, Glasier A, Wellings K, Loudon J. Myths and misconceptions about intrauterine contraception among women seeking termination of pregnancy. J Fam Plann Reprod Healthcare 2013 [Epub ahead of print]
18. Wellings K, Zhihong Z, Krentel A, Barrett G, Glasier A. Attitudes towards long-acting reversible methods of contraception in general practice in the UK. Contraception 2007;76:208-14.
19. Middleton AJ, Naish J, Singer N. General practitioners' views on the use of levonorgestrel-releasing intrauterine system in young nulligravid women, in London, UK. Eur J Contracept Reprod Health Care 2011;16:311-8.
20. Stubbs E, Schamp A. The evidence is in. Why are IUDs still out? Canadian Family Physician 2008;54:560-6.
21. Stanwood NL, Garrett JM, Konrad T. Obstetrician-Gynecologists and the intrauterine device: A survey of attitudes and practice. Obstet Gynecol 2002;99:275-80.
22. Madden T, Allsworth JE, Hladky KJ, Secura GM, Peipert JF. Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists' knowledge and attitudes. Contraception 2010;81:112-116
23. American College of Obstetricians and Gynecologists. ACOG Committee Opinion Number 450. Increasing use of Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy 2009 [Internet]. Available at http://www.acog.org/About-ACOG/ACOG-Departments/Long-Acting-Reversible- Contraception/~/media/Departments/LARC/co450.pdf [cited 2013, Ma3 18].
24. World Health Organization. Policy Brief. Eliminating systemic barriers to contraceptive services [Internet]. Available at http://apps.who.int/iris/ bitstream/10665/75l63/l/WHO-RHR-HRP-12.24-eng.pdf [cited 2013, Ma3 18].
25. Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception 2011;84:493-8.
26. Sonfield A. Popularity Disparity: Attitudes about the 1UD in Europe and the United States. Guttmacher Policy Review 2007;10:19-24.
27. Baldwin M, Rodriguez MI, Edelman AB. Lack of insurance and parity influence choice between longacting reversible contraception and sterilization in women postpregnancy. Contraception 2012;86:42-7.
28. Vaaler ML, Kalanges LK, Fonseca VP, Castrucci BC. Urban-rural differences in attitudes and practices toward long-acting reversible contraceptives among family planning providers in Texas. Womens's Health Issues 2012;22 e157-e162.
29. Lakha F, Henderson C, Glasier A. The acceptability of self-administration of subcutaneous Depo-Provera. Contraception 2005;72:14-8.
30. Whitaker AK, Johnson LM, Chiappetta L, Creinin MD, Gold MA. Adolescent and young adult women's knowledge of and attitudes toward the intrauterine device. Contraception 2008;78:211-7.
31. Whitaker AK, Terplan M, Gold MA, Johnson LM, Creinin MD, Harwood B. Effect of a brief educational intervention on the attitudes of young women toward the intrauterine device. J Pediatr Adolesc Gynecol 2010;23:116-20.
32. American College of Obstetricians and Gynecologists. Practice Bulletin. Number 121. Long-acting reversible contraception: implants and intrauterine devices 2011 [Internet]. Available at https://www.acog.org/About-ACOG/ACOG- Departments/Long-Acting-Reversible-Contraception/~/media/Departments/LARC/ PracticeBulletinl21.pdf [cited 2013, Mar. 19].
33. American College of Obstetricians and Gynecologists. LARC Program Activities. [Internet], Avalable at https://www.acog.org/About-ACOG/ACOG- Departments/Long-Acting-Reversible-Contraception/LARC-Program-Activities [cited 2013, Mar. 19].
34. Secura G, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive Choice Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010;203:115 e1-7.
35. Peipert JF, Madden T, Allsworth JE, Secura G. Preventing unintended pregnancy by providing no-cost contraception. Obstet Gynecol 2012;120:1291-7.
36. Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117:1105-13.
37. Tylee A, Haller DM, Graham T, Churchill R, Sanci LA. Youth-friendly primary-care services: How are we doing and what more needs to be done? Lancet 2007;369:1565-73.
38. Kavanaugh ML, Jerman J, Ethier K, Moskosky S. Meeting the needs of teens and young adults: youthfriendly and long-acting reversible contraceptive services in US family planning facilities. J Adolesc Health 2013;52:284-92.
39. Jain J, Dutton C, Nicosia A, Wajszczuk C, Bode FR, Mishell DR. Pharmacokinetics, ovulation suppression and return to ovulation following a lower-dose subcutaneous formulation of Depo-Provera. Contraception 2004;70:11-8.
40. Prabhakaran S, Sweet A. Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability. Contraception 2012;85:453-7.
41. Cameron ST, Glasier A, Johnstone A. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception Contraception 2012;85:458-64.
42. Williams RL, Hensel DJ, Fortenberry JD. Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women. Contraception 2013 [Epub ahead of print].
43. Picardo C, Ferreri S. Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomised controlled trial. Contraception 2010;82:160-7.
44. Cameron ST, Glasier A, Chen ZE, Johnstone A, Dunlop C, Heller R. Effect of contraception provided at termination of pregnancy and incidence of subsequent termination of pregnancy. Br J Obstet Gynaecol 2012;119:1074-80.
45. Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol 2012;206:37.el-6.
46. Goodman S, Hendlish SH, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008;78:143-8.
47. Roberts H, Silva M, Xu S. Post abortion contraception and its effect on repeat abortions in Auckland, New Zealand. Contraception 2010;82:26-265.
48. Kavanaugh ML, Carlin EE, Jones RK. Patients' attitudes and experiences related to receiving contraception during abortion care. Contraception 2011;84:585-93.
49. Schunmann C, Glasier A. Specialist contraceptive counselling and provision after termination of pregnancy improves uptake of long-acting methods but does not prevent repeat abortion: a randomized trial. Human Reproduction 2006;21:2296-303.
50. Rose SB, Lawton BA, Brown SA. Uptake and adherence to long-acting contraception post abortion. Contraception 2010;82:345-53.
51. Cameron ST, Berugoda N, Johnstone A, Glasier A. Assessment of a 'fast-track' referral service for intrauterine contraception following early medical abortion. J Fam Plann Reprod Health Care 2012;38:175-8.
52. Saav I, Stephansson O, Gemzell-Daneilsson K. Early versus delayed insertion of intrauterine contraception after medical abortion - a randomised controlled trial. PLoS One 2012;7:e48948.
53. Shimoni N, Davis A, Ramos ME, Rosario L, Westhoff C. Timing of intrauterine device insertion after medical abortion. Obstet Gynecol 2011;118:623-8.
54. McDonald E, Brown S. Does method of birth make a difference to when women resume sex after childbirth? BJOG 2013 [Epub ahead of print].
55. Lewis LN, Doherty DA, Hickey M, Skinner SR. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy. Contraception 2010;81:421-6.
56. th. Available at http://ac.els-cdn.com/S0010782412009146/1-S2.0-S0010782412009146-main.pdf?-tid= 4b345c08-90a2-lle2-b287-00000aacb3 5f&acdnat=1363703929- 96b2a88b84e6982cb3c787a6 9ab3c780 [cited 2013, Mar. 19].
57. Salcedo J, Moniaga N, Harken T, Conly B, Rao K, Narayan A. Postpartum initiation of highly effective contraception. Contraception 2011;84:343 (abstract).
58. Tocce K, Sheeder J, Python J, Teal SB. Long-acting reversible contraception in postpartum adolescents: Early initiation of etonorgestrel implant is superior to IUDs in the outpatient setting. J Pediat Adolesc Gynecol 2015;25:59-63.
59. Grimes DA, Lopez LM, Schulz KF, Van Vliet H A A M, Stanwood NL. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev 2010; CD003036.